SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001493152-23-038337
Filing Date
2023-10-26
Accepted
2023-10-26 09:00:19
Documents
2

Document Format Files

Seq Description Document Type Size
1 form424b4.htm 424B4 282090
2 forms-1_001.jpg GRAPHIC 4251
  Complete submission text file 0001493152-23-038337.txt   289267
Mailing Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540
Business Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540 609-375-2227
Sonnet BioTherapeutics Holdings, Inc. (Filer) CIK: 0001106838 (see all company filings)

IRS No.: 522102141 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 424B4 | Act: 33 | File No.: 333-274581 | Film No.: 231347639
SIC: 2834 Pharmaceutical Preparations